Skip to main content
Log in

Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The pharmacokinetics of a single 400 mg oral dose of valnoctamide (VCD) has been investigated in seven healthy, adult, male volunteers. VCD was not biotransformed rapidly to its corresponding acid valnoctic acid (VCA), unlike its isomer valpromide (VPD). It had a mean residence time of 13.2 h and a terminal half-life of 9.3 h. Throughout the study, only low plasma levels of VCA could be detected. Thus, unlike VPD, which is a prodrug of the corresponding acid, (valproic acid, VPA). VCD appears to act as a drug in its own right, and it does not undergo similar hydrolysis. The pharmacokinetic difference may account for the different pharmacological activities of the two isomers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Stepansky W (1960) A clinical study in the use of valmethamide, an anxiety reducing drug. Curr Ther Res 2: 144–149

    Google Scholar 

  2. Reynolds JEF (1982) Martindale — the extra pharmacopea, 28th edn. Pharmaceutical Press, London, p 1563

    Google Scholar 

  3. The Merck Index, 10th ed (1983) Merck, Rahway, NJ, USA, pp 9715

  4. Chambon JP, Perio A (1980) Valnoctamide: pharmacological data suggesting an antiepileptic activity. Neurosci Lett [Suppl] 5: S327-S327

    Google Scholar 

  5. Haj-Yehia A, Bialer M (1988) Pharmacokinetics of a valpromide isomer, valnoctamide, in dogs. J Pharm Sci 77: 831–834

    Google Scholar 

  6. Bialer M, Rubinstein A, Raz I, Abramsky O (1984) Pharmacokinetics of valpromide after oral administration of a solution and a tablet to healthy volunteers. Eur J Clin Pharmacol 27: 501–503

    Google Scholar 

  7. Bialer M, Rubinstein A, Dubrovsky J, Raz I, Abramsky O (1985) A comparative pharmacokinetic study of valpromide and valproic acid after intravenous administration in humans. Int J Pharm 23: 25–33

    Google Scholar 

  8. Pisani F and De Perri R (1980) Some clinical pharmacological aspects of N-dipropylacetamide. Ital J Neurol Sci 4: 245–249

    Google Scholar 

  9. Pisani F, Fazio A, Oteri G, Di Perri R (1981) Dipropylacetic acid plasma levels; diurnal fluctuations during chronic treatment with dipropyl-acetamide. Ther Drug Monit 3: 297–301

    Google Scholar 

  10. Levy RH (1984) Valproate, modern perspectives. Epilepsia 25 [Suppl 1]

  11. Bialer M, Hoch B (1985) Rapid gas chromatographic assay for monitoring valnoctamide. J Chromatogr Biomed Applic 337: 408–411

    Google Scholar 

  12. Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd ed. Dekker, New York, pp 445–449

    Google Scholar 

  13. Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd ed. Dekker, New York, pp 409–417

    Google Scholar 

  14. Yamaoka K, Nakagawa T, Uno T (1978) Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm 6: 574–588

    Google Scholar 

  15. Wilkinson GR, Shand DG (1975) A physiological approach to hepatic clearance. Clin Pharmacol Ther 18: 377–390

    Google Scholar 

  16. Yamaoka K (1986) “Methods for pharmacokinetic analysis for personal computer”, 2nd edn. Nanko-D Ltd., Tokyo, pp 145–175

    Google Scholar 

  17. Haj-Yehia A and Bialer M (1989) Structure pharmacokinetic relationships of a series of valpromide derivatives with antiepileptic activity. Pharm Res 6: 683–687

    Google Scholar 

  18. Lambert PA (1984) Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In: Emrich HM, Okama T, Muller AA (eds) Anticonvulsants in Affective Disorders. Excerpta Medica, Amsterdam, pp 33–44

    Google Scholar 

  19. Emrich HM (1987) Anti-Epileptic Agents. II. Diphenylhydantoin, Dipropylacetamide, Valproate and Progabide. In: Johnson FN (ed) Lithium combination treatment. Karger, Basel, pp 156–163

    Google Scholar 

  20. Lambert PA, Venaud G (1987) Utilization du valpromide en therapeutique psychiatrique. L' Encéphale 13: 367–373

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bialer, M., Haj-Yehia, A., Barzaghi, N. et al. Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects. Eur J Clin Pharmacol 38, 289–291 (1990). https://doi.org/10.1007/BF00315032

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00315032

Key words

Navigation